Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease

Rheumatoid arthritis (RA) is the most common immune mediated (autoimmune) rheumatic disease, manifested by chronic erosive arthritis and systemic internal organ damage. Currently, RA is considered as a syndrome characterized by clinical and pathogenetic heterogeneity associated with a variety of mec...

Full description

Saved in:
Bibliographic Details
Main Authors: E. L. Nasonov, A. S. Avdeeva, D. A. Dibrov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2023-06-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/3355
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849240217324617728
author E. L. Nasonov
A. S. Avdeeva
D. A. Dibrov
author_facet E. L. Nasonov
A. S. Avdeeva
D. A. Dibrov
author_sort E. L. Nasonov
collection DOAJ
description Rheumatoid arthritis (RA) is the most common immune mediated (autoimmune) rheumatic disease, manifested by chronic erosive arthritis and systemic internal organ damage. Currently, RA is considered as a syndrome characterized by clinical and pathogenetic heterogeneity associated with a variety of mechanisms of pathological activation of innate and acquired immunity, determining the variability of the course and outcome of the inflammatory process and effectiveness of therapy. Based on the detection or absence of rheumatoid factor (RF) IgM and antibodies to cyclic citrullinated peptides (ACCP), RA can be conventionally divided into two subtypes (phenotypes): seropositive RA and seronegative RA, but thanks to improvement of laboratory diagnostic methods the spectrum of autoantibodies detected in RA has increased significantly. Diagnosis of seronegative RA based on classification (rather than diagnostic) criteria can be difficult, especially in the early stages of the disease, and the diagnosis is made only during long-term follow-up of patients. It complicates the timely prescription of adequate anti-inflammatory therapy. This article summarizes the data on genetic predisposition, immunopathogenesis, biomarkers, clinical spectrum, instrumental diagnosis and pharmacotherapy of seronegative RA.
format Article
id doaj-art-689e53bdd93045eeb071c668ef028f20
institution Kabale University
issn 1995-4484
1995-4492
language Russian
publishDate 2023-06-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-689e53bdd93045eeb071c668ef028f202025-08-20T04:00:40ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922023-06-0161327629110.47360/1995-4484-2023-276-2912900Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the diseaseE. L. Nasonov0A. S. Avdeeva1D. A. Dibrov2V.A. Nasonova Research Institute of Rheumatology; I.M. Sechenov First Moscow State Medical University of the Ministry of Health Care of Russian Federation (Sechenov University)V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyRheumatoid arthritis (RA) is the most common immune mediated (autoimmune) rheumatic disease, manifested by chronic erosive arthritis and systemic internal organ damage. Currently, RA is considered as a syndrome characterized by clinical and pathogenetic heterogeneity associated with a variety of mechanisms of pathological activation of innate and acquired immunity, determining the variability of the course and outcome of the inflammatory process and effectiveness of therapy. Based on the detection or absence of rheumatoid factor (RF) IgM and antibodies to cyclic citrullinated peptides (ACCP), RA can be conventionally divided into two subtypes (phenotypes): seropositive RA and seronegative RA, but thanks to improvement of laboratory diagnostic methods the spectrum of autoantibodies detected in RA has increased significantly. Diagnosis of seronegative RA based on classification (rather than diagnostic) criteria can be difficult, especially in the early stages of the disease, and the diagnosis is made only during long-term follow-up of patients. It complicates the timely prescription of adequate anti-inflammatory therapy. This article summarizes the data on genetic predisposition, immunopathogenesis, biomarkers, clinical spectrum, instrumental diagnosis and pharmacotherapy of seronegative RA.https://rsp.mediar-press.net/rsp/article/view/3355rheumatoid arthritis seropositive rheumatoid arthritisseronegative rheumatoid arthritisrheumatoid factoranti-citrullinated protein antibodiesnew autoantibodies in rheumatoid arthritis
spellingShingle E. L. Nasonov
A. S. Avdeeva
D. A. Dibrov
Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease
Научно-практическая ревматология
rheumatoid arthritis seropositive rheumatoid arthritis
seronegative rheumatoid arthritis
rheumatoid factor
anti-citrullinated protein antibodies
new autoantibodies in rheumatoid arthritis
title Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease
title_full Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease
title_fullStr Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease
title_full_unstemmed Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease
title_short Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease
title_sort rheumatoid arthritis as a clinical and immunological syndrome focus on the seronegative subtype of the disease
topic rheumatoid arthritis seropositive rheumatoid arthritis
seronegative rheumatoid arthritis
rheumatoid factor
anti-citrullinated protein antibodies
new autoantibodies in rheumatoid arthritis
url https://rsp.mediar-press.net/rsp/article/view/3355
work_keys_str_mv AT elnasonov rheumatoidarthritisasaclinicalandimmunologicalsyndromefocusontheseronegativesubtypeofthedisease
AT asavdeeva rheumatoidarthritisasaclinicalandimmunologicalsyndromefocusontheseronegativesubtypeofthedisease
AT dadibrov rheumatoidarthritisasaclinicalandimmunologicalsyndromefocusontheseronegativesubtypeofthedisease